Condition
Non Traumatic Osteonecrosis of the Femoral Head (Hip)
Total Trials
2
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
3 treatments under study, led by Core Decompression Of The Femoral Head
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 2 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
Early P 1 (1)
Trial Status
Completed1
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (2)
Showing 2 of 2 trials
NCT07787923Early Phase 1Not Yet RecruitingPrimary
Safety, Tolerability, and Preliminary Efficacy of Intra-Articular Injection of Mesenchymal Stem Cell-Derived Exosomes for the Treatment of Non-Traumatic Avascular Necrosis of the Femoral Head
NCT01544712Not ApplicableCompletedPrimary
Controlled Study of Stage 3 Osteonecrosis Treatment by Bone Marrow
Showing all 2 trials
Research Network
Common Treatments
- Core Decompression Of The Femoral Head1
- Core Decompression With Autologous Bone Marrow Implantation1
- Exosome Intervention Group1
Active Sponsors
- University Of Liege1
- Beijing Jishuitan Hospital1
- Carrier Biomed Suzhou Co Ltd1